Atlas Trials

Individual Patient Expanded Access-Glembatumumab Vedotin

Clinical trial NCT03067935 · NO_LONGER_AVAILABLE

Trial details

NCT number
NCT03067935
Sponsor
Celldex Therapeutics
Status
NO_LONGER_AVAILABLE
Study type
EXPANDED_ACCESS
Metastatic gpNMB Expressing Triple Negative Breast Cancer

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.